203 related articles for article (PubMed ID: 12584469)
1. Tumours after kidney transplantation.
Lutz J; Heemann U
Curr Opin Urol; 2003 Mar; 13(2):105-9. PubMed ID: 12584469
[TBL] [Abstract][Full Text] [Related]
2. Post-renal transplant malignancies: Opportunities for prevention and early screening.
Turshudzhyan A
Cancer Treat Res Commun; 2021; 26():100283. PubMed ID: 33338850
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of malignancies after kidney transplantation in adults: Slovak multicenter experience.
Zilinska Z; Sersenova M; Chrastina M; Breza J; Bena L; Baltesova T; Jurcina A; Roland R; Lackova E; Cellar M; Laca L; Dedinska I
Neoplasma; 2017; 64(2):311-317. PubMed ID: 28052685
[TBL] [Abstract][Full Text] [Related]
4. De-novo malignancies after kidney transplantation: A long-term observational study.
Fröhlich FA; Halleck F; Lehner L; Schrezenmeier EV; Naik M; Schmidt D; Khadzhynov D; Kast K; Budde K; Staeck O
PLoS One; 2020; 15(11):e0242805. PubMed ID: 33253202
[TBL] [Abstract][Full Text] [Related]
5. Malignancies in renal transplantation: an unmet medical need.
Dantal J; Pohanka E
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i4-10. PubMed ID: 17456618
[TBL] [Abstract][Full Text] [Related]
6. Malignancy after transplantation.
Buell JF; Gross TG; Woodle ES
Transplantation; 2005 Oct; 80(2 Suppl):S254-64. PubMed ID: 16251858
[TBL] [Abstract][Full Text] [Related]
7. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
[TBL] [Abstract][Full Text] [Related]
8. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
9. Malignancy in kidney transplant recipients.
Kapoor A
Drugs; 2008; 68 Suppl 1():11-9. PubMed ID: 18442297
[TBL] [Abstract][Full Text] [Related]
10. Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.
Braconnier P; Del Marmol V; Broeders N; Kianda M; Massart A; Lemy A; Ghisdal L; Le Moine A; Madhoun P; Racapé J; Abramowicz D; Wissing KM
Nephrol Dial Transplant; 2012 Jun; 27(6):2547-53. PubMed ID: 22123748
[TBL] [Abstract][Full Text] [Related]
11. [Development of primary malignancies after liver and kidney transplantation and the treatment approach].
Bechstein WO; Dette K; Golling M; Wullstein Ch
Kongressbd Dtsch Ges Chir Kongr; 2002; 119():398-404. PubMed ID: 12704897
[TBL] [Abstract][Full Text] [Related]
12. [Infectious and neoplasic complications after kidney transplantation].
Mourad G; Serre JE; Alméras C; Basel O; Garrigue V; Pernin V; Le Quintrec M
Nephrol Ther; 2016 Nov; 12(6):468-487. PubMed ID: 27686031
[TBL] [Abstract][Full Text] [Related]
13. Malignancy after Solid Organ Transplantation: Comprehensive Imaging Review.
Katabathina VS; Menias CO; Tammisetti VS; Lubner MG; Kielar A; Shaaban A; Mansour J; Surabhi VR; Hara AK
Radiographics; 2016; 36(5):1390-407. PubMed ID: 27618321
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H
J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
Bhat M; Mara K; Dierkhising R; Watt KDS
Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826
[TBL] [Abstract][Full Text] [Related]
16. Donor-transmitted, donor-derived, and de novo cancer after liver transplant.
Chapman JR; Lynch SV
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():50-4. PubMed ID: 24635793
[TBL] [Abstract][Full Text] [Related]
17. Alemtuzumab induction in deceased donor kidney transplantation.
Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
[TBL] [Abstract][Full Text] [Related]
18. Malignancies after pediatric kidney transplantation: more than PTLD?
Mynarek M; Hussein K; Kreipe HH; Maecker-Kolhoff B
Pediatr Nephrol; 2014 Sep; 29(9):1517-28. PubMed ID: 24061645
[TBL] [Abstract][Full Text] [Related]
19. [Malignant neoplasms and kidney transplantation].
Serrallach N; Riera LL; Franco E; Aguiló F; Muñoz J; López-Costea MA; Camps N; Serra J; González C; Castelao AM
Actas Urol Esp; 1994 Sep; 18(8):801-7. PubMed ID: 7998508
[TBL] [Abstract][Full Text] [Related]
20. Cancer after renal transplantation.
Vasudev B; Hariharan S
Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):523-8. PubMed ID: 18089965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
